Stock Analiz

Relay Therapeutics, Inc. (RLAY) stock forecast and price target

Price $18.09 · data as of November 13, 2026

12-month price target

Average target$28.25
Upside / downside+56.2%
Analysts12
ConsensusStrong buy
Low $25.00Average $28.25High $32.00

Gold marker: average target · white marker: today’s price ($18.09)

Analyst ratings

Strong buy 3Buy 9Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-1.56+3.4%$7M
Next fiscal year
ends December 31, 2027
$-1.57−1.0%$11M
Next quarter
ends December 31, 2026
$-0.35−14.2%$6M
Quarter after
ends March 31, 2027
$-0.38+6.4%$720000

Consensus of the analysts covering Relay Therapeutics, updated daily. In the last 30 days 4 estimates were raised and 1 lowered.

Frequently asked questions

What is the Relay Therapeutics stock price target?

The average 12-month target from 12 analysts is $28.25, 56.2% above the current price of $18.09 Targets range from $25.00 to $32.00.

Is Relay Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (3 strong buy, 9 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Relay Therapeutics expected to earn?

Analysts expect EPS of $-1.56 for the fiscal year ending December 31, 2026 and $-1.57 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.